The MICELab group is researching in technologies for diabetes since 2004, reaching more than two billion euros funding in various competing projects. The group has worked on modeling and control in diabetes, glucose prediction including uncertainty and intra-patient variability, optimizing insulin therapy, identification of models of carbohydrate absorption and gastric emptying, calibration algorithms for continuous glucose monitors, development control algorithms for closed-loop type 1 diabetic patients and also for critically ill patients and fault detection in continuous monitors and insulin pumps. In the last five years, the group has published more than 25 articles on PubMed journals about developing technologies for diabetes and has requested 3 patents.